|
|
|
 |
FDA Approval Activities for this Drug…
Megace (megestrol acetate) Suspension, Bristol Myers Squibb Co. NDA 20-264/S-011 5/1/03 7/9/03 Megace (megestrol acetate) Suspension, Bristol Myers Squibb Co. NDA 20-264/S-009 4/9/02 4/16/02 Megace (megestrol acetate) Tablets, Bristol Myers Squibb Co. NDA 16-979/S-052 1/6/02 1/23/03 Megace (megestrol acetate) Tablets, Bristol Myers Squibb Co. NDA 16-979/S-051 8/27/02 8/30/02 Megestrol Acetate Suspension, 40 mg/mL., Roxane, ANDA 75-997 2/15/02 Megestrol Acetate Suspension, 40 mg/mL., Copley Pharmaceutical ANDA 75-681 5/5/03 Megestrol Acetate Suspension, 40 mg/mL., Par Pharmaceutical, ANDA 75-671 7/25/01 1/17/02 1/17/02 Megestrol Acetate Suspension, 40 mg/mL., Par Pharmaceutical, ANDA 75-671 10/23/00 11/7/00 Megestrol Acetate Tablets USP, 40 mg. Pharmachemie B.V. ANDA 74-745 MEGESTROL ACETATE Suspension; 40MG/ML MEGACE BRISTOL MYERS SQUIBB 075681 MEGESTROL ACETATE Suspension; 40MG/ML MEGESTROL ACETATE Copley 075671 MEGESTROL ACETATE Suspension; 40MG/ML MEGESTROL ACETATE Par 075997 MEGESTROL ACETATE Suspension; 40MG/ML MEGESTROL ACETATE Roxane 074621 MEGESTROL ACETATE Tablet; 20MG MEGESTROL ACETATE Barr 074621 MEGESTROL ACETATE Tablet; 40MG MEGESTROL ACETATE Barr 016979 MEGESTROL ACETATE Tablet; 20MG MEGACE BRISTOL MYERS SQUIBB 016979 MEGESTROL ACETATE Tablet; 40MG MEGACE BRISTOL MYERS SQUIBB 072422 MEGESTROL ACETATE Tablet; 20MG MEGESTROL ACETATE Par 072423 MEGESTROL ACETATE Tablet; 40MG MEGESTROL ACETATE Par 074458 MEGESTROL ACETATE Tablet; 20MG MEGESTROL ACETATE Roxane 074458 MEGESTROL ACETATE Tablet; 40MG MEGESTROL ACETATE Roxane 074745 MEGESTROL ACETATE Tablet; 40MG MEGESTROL ACETATE Teva | Megestrol Acetate Oral Suspension, Morton Grove, Approval | Megace ES (megestrol acetate) Oral Suspension, Par Pharma, Approval | Megestrol Acetate Oral Suspension, Apotex, Approval | Megace ES (megestrol acetate) Oral Suspension, Par Pharma, Labeling Revision | Megace ES (megestrol acetate) Oral Suspension, Par Pharmaceutical, Inc., Labeling Revision | Megace ES (megestrol acetate) Oral Suspension, Par Pharmaceutical, Approval
  
|